{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:10:15Z","timestamp":1791022215302,"version":"4.1.0"},"reference-count":39,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,9,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Programmed cell death or apoptosis is a prominent feature of low-risk myelodysplastic syndromes (MDS), although the underlying mechanism remains controversial. High-risk MDS have less apoptosis associated with increased expression of the prosurvival BCL2-related proteins. To address the mechanism and pathogenic role of apoptosis and BCL2 expression in MDS, we used a mouse model resembling human MDS, in which the fusion protein NUP98-HOXD13 (NHD13) of the chromosomal translocation t(2;11)(q31;p15) is expressed in hematopoietic cells. Hematopoietic stem and progenitor cells from 3-month-old mice had increased rates of apoptosis associated with increased cell cycling and DNA damage. Gene expression profiling of these MDS progenitors revealed a specific reduction in Bcl2. Restoration of Bcl2 expression by a BCL2 transgene blocked apoptosis of the MDS progenitors, which corrected the macrocytic anemia. Blocking apoptosis also restored cell-cycle quiescence and reduced DNA damage in the MDS progenitors. We expected that preventing apoptosis would accelerate malignant transformation to acute myeloid leukemia (AML). However, contrary to expectations, preventing apoptosis of premalignant cells abrogated transformation to AML. In contrast to the current dogma that overcoming apoptosis is an important step toward cancer, this work demonstrates that gaining a survival advantage of premalignant cells may delay or prevent leukemic progression.<\/jats:p>","DOI":"10.1182\/blood-2012-05-430736","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T02:20:21Z","timestamp":1343787621000},"page":"2475-2483","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":41,"title":["Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome"],"prefix":"10.1182","volume":"120","author":[{"given":"Christopher I.","family":"Slape","sequence":"first","affiliation":[{"name":"Bone Marrow Research Laboratories, Royal Melbourne Hospital, Parkville, Australia;"},{"name":"Division of Blood Cancers, Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesslyn","family":"Saw","sequence":"additional","affiliation":[{"name":"Bone Marrow Research Laboratories, Royal Melbourne Hospital, Parkville, Australia;"},{"name":"Division of Blood Cancers, Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy B. M.","family":"Jowett","sequence":"additional","affiliation":[{"name":"Genomics and Systems Biology, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Aplan","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Strasser","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia;"},{"name":"Department of Medical Biology, The University of Melbourne, Melbourne, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Jane","sequence":"additional","affiliation":[{"name":"Bone Marrow Research Laboratories, Royal Melbourne Hospital, Parkville, Australia;"},{"name":"Division of Blood Cancers, Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia;"},{"name":"Department of Clinical Hematology, Alfred Hospital, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Curtis","sequence":"additional","affiliation":[{"name":"Bone Marrow Research Laboratories, Royal Melbourne Hospital, Parkville, Australia;"},{"name":"Division of Blood Cancers, Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia;"},{"name":"Department of Clinical Hematology, Alfred Hospital, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"19","key":"2019111808280734900_B1","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra0902908","article-title":"Myelodysplastic syndromes.","volume":"361","author":"Tefferi","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111808280734900_B2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death.","volume":"9","author":"Youle","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"2019111808280734900_B3","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.exphem.2007.09.007","article-title":"Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome.","volume":"35","author":"Kerbauy","year":"2007","journal-title":"Exp Hematol"},{"issue":"1","key":"2019111808280734900_B4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nm.2063","article-title":"A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.","volume":"16","author":"Barlow","year":"2010","journal-title":"Nat Med"},{"issue":"5868","key":"2019111808280734900_B5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.1140735","article-title":"An oncogene-induced DNA damage model for cancer development.","volume":"319","author":"Halazonetis","year":"2008","journal-title":"Science"},{"issue":"5","key":"2019111808280734900_B6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"12","key":"2019111808280734900_B7","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood.V96.12.3932","article-title":"The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.","volume":"96","author":"Parker","year":"2000","journal-title":"Blood"},{"issue":"1","key":"2019111808280734900_B8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2004-12-4794","article-title":"NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.","volume":"106","author":"Lin","year":"2005","journal-title":"Blood"},{"issue":"5","key":"2019111808280734900_B9","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1182\/blood-2008-01-135186","article-title":"Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl.","volume":"112","author":"Slape","year":"2008","journal-title":"Blood"},{"issue":"9","key":"2019111808280734900_B10","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.186.9.1585","article-title":"Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting.","volume":"186","author":"K\u00f6rner","year":"1997","journal-title":"J Exp Med"},{"issue":"1","key":"2019111808280734900_B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.159.1.1","article-title":"A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H\/HeJ mice.","volume":"159","author":"Roths","year":"1984","journal-title":"J Exp Med"},{"issue":"26","key":"2019111808280734900_B12","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1073\/pnas.96.26.14943","article-title":"Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.","volume":"96","author":"Ogilvy","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2019111808280734900_B13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000204502","article-title":"Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.","volume":"89","author":"Dan","year":"1993","journal-title":"Acta Haematol"},{"issue":"6","key":"2019111808280734900_B14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0145-2126(01)00170-9","article-title":"Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome.","volume":"26","author":"Lin","year":"2002","journal-title":"Leuk Res"},{"issue":"3-4","key":"2019111808280734900_B15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10428190009089441","article-title":"Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome.","volume":"37","author":"Deeg","year":"2000","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2019111808280734900_B16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1074-7613(00)80609-3","article-title":"Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas\/Apo1, and DR3 and is lethal prenatally.","volume":"9","author":"Varfolomeev","year":"1998","journal-title":"Immunity"},{"issue":"2","key":"2019111808280734900_B17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MOH.0b013e32801684b6","article-title":"The role of HOX genes in malignant myeloid disease.","volume":"14","author":"Eklund","year":"2007","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"2019111808280734900_B18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/leu.2010.31","article-title":"Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.","volume":"24","author":"Pellagatti","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"2019111808280734900_B19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ajh.10108","article-title":"Expression and prognostic significance of Bcl-2 family proteins in myelodysplastic syndromes.","volume":"70","author":"Boudard","year":"2002","journal-title":"Am J Hematol"},{"issue":"12","key":"2019111808280734900_B20","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1084\/jem.192.12.1707","article-title":"Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl\/c-Kit signaling the other.","volume":"192","author":"Domen","year":"2000","journal-title":"J Exp Med"},{"issue":"12","key":"2019111808280734900_B21","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0145-2126(98)00112-X","article-title":"Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment.","volume":"22","author":"Greenberg","year":"1998","journal-title":"Leuk Res"},{"issue":"32","key":"2019111808280734900_B22","doi-asserted-by":"crossref","first-page":"13135","DOI":"10.1073\/pnas.1110358108","article-title":"Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1.","volume":"108","author":"Croker","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7258","key":"2019111808280734900_B23","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08229","article-title":"XIAP discriminates between type I and type II FAS-induced apoptosis.","volume":"460","author":"Jost","year":"2009","journal-title":"Nature"},{"issue":"1","key":"2019111808280734900_B24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.immuni.2008.10.017","article-title":"Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim.","volume":"30","author":"Kaufmann","year":"2009","journal-title":"Immunity"},{"issue":"5","key":"2019111808280734900_B25","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.2337\/db07-1692","article-title":"Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic beta-cells.","volume":"57","author":"McKenzie","year":"2008","journal-title":"Diabetes"},{"issue":"24","key":"2019111808280734900_B26","doi-asserted-by":"crossref","first-page":"11657","DOI":"10.1158\/0008-5472.CAN-07-0196","article-title":"BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia.","volume":"67","author":"Omidvar","year":"2007","journal-title":"Cancer Res"},{"issue":"15","key":"2019111808280734900_B27","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/sj.onc.1201353","article-title":"Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice.","volume":"15","author":"J\u00e4ger","year":"1997","journal-title":"Oncogene"},{"issue":"3","key":"2019111808280734900_B28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(02)00738-9","article-title":"Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.","volume":"109","author":"Pelengaris","year":"2002","journal-title":"Cell"},{"issue":"6299","key":"2019111808280734900_B29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/348331a0","article-title":"Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.","volume":"348","author":"Strasser","year":"1990","journal-title":"Nature"},{"issue":"6","key":"2019111808280734900_B30","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2003-07-2469","article-title":"VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.","volume":"103","author":"Egle","year":"2004","journal-title":"Blood"},{"issue":"15","key":"2019111808280734900_B31","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1101\/gad.1940110","article-title":"Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death.","volume":"24","author":"Michalak","year":"2010","journal-title":"Genes Dev"},{"issue":"15","key":"2019111808280734900_B32","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1101\/gad.1940210","article-title":"Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation.","volume":"24","author":"Labi","year":"2010","journal-title":"Genes Dev"},{"issue":"10","key":"2019111808280734900_B33","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/leu.2008.172","article-title":"Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum.","volume":"22","author":"Gyan","year":"2008","journal-title":"Leukemia"},{"issue":"4","key":"2019111808280734900_B34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1084\/jem.193.4.531","article-title":"BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia.","volume":"193","author":"Kogan","year":"2001","journal-title":"J Exp Med"},{"issue":"37","key":"2019111808280734900_B35","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.1073\/pnas.0804507105","article-title":"Transplantation of a myelodysplastic syndrome by a long-term repopulating hematopoietic cell.","volume":"105","author":"Chung","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2019111808280734900_B36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.stem.2010.07.006","article-title":"Differential DNA damage response in stem and progenitor cells.","volume":"7","author":"Seita","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2019111808280734900_B37","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cell.2011.10.033","article-title":"Programmed cell death in animal development and disease.","volume":"147","author":"Fuchs","year":"2011","journal-title":"Cell"},{"issue":"24","key":"2019111808280734900_B38","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1002\/j.1460-2075.1996.tb01090.x","article-title":"The cell death inhibitor Bcl-2 and its homologues influence control of cell-cycle entry.","volume":"15","author":"O'Reilly","year":"1996","journal-title":"EMBO J"},{"issue":"7","key":"2019111808280734900_B39","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nm.2385","article-title":"Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy.","volume":"17","author":"Huang","year":"2011","journal-title":"Nat Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/12\/2475\/1356251\/zh803812002475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/12\/2475\/1356251\/zh803812002475.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T08:51:11Z","timestamp":1574067071000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/12\/2475\/30577\/Inhibition-of-apoptosis-by-BCL2-prevents-leukemic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,20]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,9,20]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-05-430736","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,20]]}}}